671 related articles for article (PubMed ID: 32089240)
1. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.
Zhang J; Wu C; Gao L; Du G; Qin X
Adv Pharmacol; 2020; 87():89-112. PubMed ID: 32089240
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of Astragaloside IV: a literature review.
Ren S; Zhang H; Mu Y; Sun M; Liu P
J Tradit Chin Med; 2013 Jun; 33(3):413-6. PubMed ID: 24024343
[TBL] [Abstract][Full Text] [Related]
3. Research review on the pharmacological effects of astragaloside IV.
Li L; Hou X; Xu R; Liu C; Tu M
Fundam Clin Pharmacol; 2017 Feb; 31(1):17-36. PubMed ID: 27567103
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV prevents high glucose‑induced cell apoptosis and inflammatory reactions through inhibition of the JNK pathway in human umbilical vein endothelial cells.
You L; Fang Z; Shen G; Wang Q; He Y; Ye S; Wang L; Hu M; Lin Y; Liu M; Jiang A
Mol Med Rep; 2019 Mar; 19(3):1603-1612. PubMed ID: 30628687
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
6. [Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects].
You LZ; Lin YX; Fang ZH; Shen GM; Zhao JD; Wang TT
Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4700-4706. PubMed ID: 29493134
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis and Pharmacological Activities of Flavonoids, Triterpene Saponins and Polysaccharides Derived from
Dong M; Li J; Yang D; Li M; Wei J
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446680
[No Abstract] [Full Text] [Related]
8. Beneficial effects of Astragaloside IV for hair loss via inhibition of Fas/Fas L-mediated apoptotic signaling.
Kim MH; Kim SH; Yang WM
PLoS One; 2014; 9(3):e92984. PubMed ID: 24676213
[TBL] [Abstract][Full Text] [Related]
9. Protective role of Astragaloside IV in chronic glomerulonephritis by activating autophagy through PI3K/AKT/AS160 pathway.
Lu R; Chen J; Liu B; Lin H; Bai L; Zhang P; Chen D; Li H; Li J; Pang Y; Zhou Y; Zhou J; Wu J
Phytother Res; 2020 Dec; 34(12):3236-3248. PubMed ID: 32726508
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV, a saponin from Astragalus membranaceus var. mongholicus, induces expressions of heme recycle proteins via signaling of Nrf2/ARE in cultured macrophages.
Gong G; Yu H; Zheng Y; Qi B; He H; Yin T; Dong TT; Tsim KW
J Ethnopharmacol; 2021 Jan; 265():113389. PubMed ID: 32920134
[TBL] [Abstract][Full Text] [Related]
11. Protective Effects of Astragaloside IV against LPS-Induced Endometritis in Mice through Inhibiting Activation of the NF-κB, p38 and JNK Signaling Pathways.
Wang F; Chen S; Deng L; Chen L; Huang Y; Tian M; Li C; Zhou X
Molecules; 2019 Jan; 24(2):. PubMed ID: 30669661
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory cycloartane-type saponins of Astragalus membranaceus.
Lee DY; Noh HJ; Choi J; Lee KH; Lee MH; Lee JH; Hong Y; Lee SE; Kim SY; Kim GS
Molecules; 2013 Mar; 18(4):3725-32. PubMed ID: 23529032
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV Regulates the PI3K/Akt/HO-1 Signaling Pathway and Inhibits H9c2 Cardiomyocyte Injury Induced by Hypoxia-Reoxygenation.
Yang P; Zhou Y; Xia Q; Yao L; Chang X
Biol Pharm Bull; 2019 May; 42(5):721-727. PubMed ID: 30867343
[TBL] [Abstract][Full Text] [Related]
14. Research progress of astragaloside IV in the treatment of atopic diseases.
Yu S; Peng W; Qiu F; Zhang G
Biomed Pharmacother; 2022 Dec; 156():113989. PubMed ID: 36411656
[TBL] [Abstract][Full Text] [Related]
15. Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation.
Yang Y; Hong M; Lian WW; Chen Z
World J Clin Cases; 2022 Oct; 10(28):10004-10016. PubMed ID: 36246793
[No Abstract] [Full Text] [Related]
16. Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation.
Qiu LH; Xie XJ; Zhang BQ
Biol Pharm Bull; 2010; 33(4):641-6. PubMed ID: 20410599
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy.
Wang E; Wang L; Ding R; Zhai M; Ge R; Zhou P; Wang T; Fang H; Wang J; Huang J
Pharmacol Res; 2020 Jul; 157():104831. PubMed ID: 32339782
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway.
Cheng X; Gu J; Zhang M; Yuan J; Zhao B; Jiang J; Jia X
Int Immunopharmacol; 2014 Nov; 23(1):304-13. PubMed ID: 25218161
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury.
Tang JL; Xin M; Zhang LC
Aging (Albany NY); 2022 Jul; 14(14):5855-5877. PubMed ID: 35859295
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases.
Tan YQ; Chen HW; Li J
Drug Des Devel Ther; 2020; 14():3731-3746. PubMed ID: 32982178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
